Highlights from the 6th Annual Precision Medicine Symposium
The 6th Annual Precision Medicine Symposium took place from October 18th and 19th 2024.
It recently took place as a two-day live conference focused on integrating precision medicine into the treatment of solid tumors and hematologic malignancies. Participants benefited from expert insights on the latest targeted therapies, including discussions on next-generation sequencing, liquid biopsies, and cytogenetic testing for developing personalized treatment plans.
Engaging lectures and interactive sessions featured illustrated tumor boards, where community oncologists presented complex cases to leading specialists, fostering evidence-based treatment strategies.
Additionally, the symposium included lively Medical Crossfire® debates, addressing the readiness of cutting-edge therapies and technologies for clinical application, providing attendees with vital updates and expert perspectives essential for enhancing patient care.
Doctors and Healthcare Professionals shared their insights on social media:
“Precision medicine for HR+ metastatic breast cancer: from hope to reality in little more than 5 years.
2018: first PARP inhibitors (olaparib and talazoparib)
2019: first PI3K inhibitor (alpelisib)
2022 first ADC for HR+ disease (T-DXd)
2023 first oral SERD for ESR1-mutant cancers (elacestrant) + first AKT inhibitor (capivasertib) + second ADC (SG)
2024 first triplet for PIK3CA-mutant tumors (inavolisib triplet)
A honor to have the chance to review this evolving landscape with my mentor Sara Tolaney at the 6th PER Precision Medicine Symposium.”
“Monique Hartley-Brown vs Diana Cirstea took on a medical crossfire – Should We Treat Smoldering Myeloma?
‘We need risk mitigation models’.”
“Diana Cirstea explores the use of CAR T-Cell therapy into clinical care.”
“Excited to be watching the tumor board at the Precision Medicine Symposium RIGHT NOW!
Experts coming together to tackle complex cases and advance tailored cancer care. Let’s keep pushing the boundaries of what’s possible in precision oncology.”
“Colleagues that are now friends – precision oncology discussion in GI and GU oncology with experts in the field
In a beautiful fall day in Boston.”
PER:
“The 6th Annual Precision Medicine Symposium was a success! Experts shared the latest insights on personalized care and cutting-edge therapies, helping attendees apply new strategies to improve patient outcomes!”
For more posts like this, visit oncodaily.com
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023